SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-19-003809
Filing Date
2019-02-22
Accepted
2019-02-22 07:47:07
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 odt-s3.htm S-3 199191
2 EX-5.1 odt-ex51_15.htm EX-5.1 21002
3 EX-23.1 odt-ex231_16.htm EX-23.1 3082
4 GRAPHIC ggdf0q5trvs5000001.jpg GRAPHIC 89690
5 GRAPHIC g31qrgsixbwv000001.jpg GRAPHIC 4471
  Complete submission text file 0001564590-19-003809.txt   354348
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-229785 | Film No.: 19623968
SIC: 2834 Pharmaceutical Preparations